Edward Wirth - Net Worth and Insider Trading
Edward Wirth Net Worth
The estimated net worth of Edward Wirth is at least $0 dollars as of 2024-05-27. Edward Wirth is the Chief Medical Officer of Asterias Biotherapeutics Inc and owns about 0 shares of Asterias Biotherapeutics Inc (AST) stock worth over $0. Details can be seen in Edward Wirth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Edward Wirth has not made any transactions after 2017-01-09 and currently still holds the listed stock(s).
Transaction Summary of Edward Wirth
Edward Wirth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Edward Wirth owns 3 companies in total, including Lineage Cell Therapeutics Inc (LCTX) , Asterias Biotherapeutics Inc (AST) , and InVivo Therapeutics Holdings Corp (NVIVQ) .
Click here to see the complete history of Edward Wirth’s form 4 insider trades.
Insider Ownership Summary of Edward Wirth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2019-03-19 | Chief Medical Officer |
| AST | Asterias Biotherapeutics Inc | 2019-03-01 | Chief Medical Officer |
| NVIVQ | InVivo Therapeutics Holdings Corp | 2011-12-05 | Chief Science Officer |
Edward Wirth Latest Holdings Summary
Edward Wirth currently owns a total of 1 stock. Edward Wirth owns 0 shares of Asterias Biotherapeutics Inc (AST) as of January 9, 2017, with a value of $0.
Latest Holdings of Edward Wirth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AST | Asterias Biotherapeutics Inc | 2017-01-09 | 0 | 0.95 | 0 |
Holding Weightings of Edward Wirth
Edward Wirth Form 4 Trading Tracker
According to the SEC Form 4 filings, Edward Wirth has made a total of 0 transactions in Asterias Biotherapeutics Inc (AST) over the past 5 years. The most-recent trade in Asterias Biotherapeutics Inc is the sale of 3,415 shares on January 9, 2017, which brought Edward Wirth around $15,709.
Insider Trading History of Edward Wirth
- 1
Edward Wirth Trading Performance
Edward Wirth Ownership Network
Edward Wirth Owned Company Details
What does Lineage Cell Therapeutics Inc do?
Who are the key executives at Lineage Cell Therapeutics Inc?
Edward Wirth is the Chief Medical Officer of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include 10 percent owner Broadwood Partners Lp , Chief Financial Officer Jill Ann Howe , and director & President and CEO Brian M Culley .
Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary
Over the past 18 months, Edward Wirth made no insider transaction in Lineage Cell Therapeutics Inc (LCTX). Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 6,730,770 shares made by Broadwood Partners Lp , a net purchase of 96,155 shares made by Don M Bailey , and a net purchase of 10,000 shares made by Anula Jayasuriya .
In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 6,836,925 shares were bought by its insiders, resulting in a net purchase of 6,836,925 shares.
Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lineage Cell Therapeutics Inc Insider Transactions
Edward Wirth Mailing Address
Above is the net worth, insider trading, and ownership report for Edward Wirth. You might contact Edward Wirth via mailing address: C/o Invivo Therapeutics Holding Corp., One Broadway, 14th Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
